User profiles for S. Halabi

Susan Halabi, PhD, FSCT, FASA, FASCO

- Verified email at duke.edu - Cited by 33147

Safwan S. Halabi, MD

- Verified email at northwestern.edu - Cited by 7771

Systematic literature review of imaging features of spinal degeneration in asymptomatic populations

…, LE Chen, RA Deyo, S Halabi… - American journal …, 2015 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Degenerative changes are commonly found in spine
imaging but often occur in pain-free individuals as well as those with back pain. We sought to …

[HTML][HTML] Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) …

…, JS De Bono, E Efstathiou, K Fizazi, S Halabi… - Annals of …, 2015 - Elsevier
The first St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert
Panel identified and reviewed the available evidence for the ten most important areas of …

[HTML][HTML] Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety

…, H Hasan, S Halabi, S Abdelhady… - Frontiers in …, 2020 - frontiersin.org
… Salvianolic acid B, one of the pure compounds that can be extracted from S. miltiorrhiza, is
effective against fibrosis and ischemia–reperfusion injury (Lay et al., 2003). Danshen has a …

Chexpert: A large chest radiograph dataset with uncertainty labels and expert comparison

…, K Shpanskaya, J Seekins, DA Mong, SS Halabi… - Proceedings of the AAAI …, 2019 - aaai.org
Large, labeled datasets have driven deep learning methods to achieve expert-level
performance on a variety of medical imaging tasks. We present CheXpert, a large dataset that …

[HTML][HTML] A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

…, S Halabi, JA Baron, S Budinger… - … England Journal of …, 2003 - Mass Medical Soc
Background Experimental studies in animals and observational studies in humans suggest
that regular aspirin use may decrease the risk of colorectal adenomas, the precursors to most …

[HTML][HTML] Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3

…, PS Nelson, LH Schwartz, S Halabi… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Evolving treatments, disease phenotypes, and biology, together with a changing
drug development environment, have created the need to revise castration-resistant prostate …

[HTML][HTML] Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate …

HI Scher, S Halabi, I Tannock, M Morris… - Journal of clinical …, 2008 - ncbi.nlm.nih.gov
… input was included during development of the measure(s); that the content and the construct
were validated; and that the measure(s) were reliable for the population being studied. A …

[HTML][HTML] Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206

BI Rini, S Halabi, JE Rosenberg… - Journal of Clinical …, 2008 - ncbi.nlm.nih.gov
… Although all authors completed the disclosure declaration, the following author(s) indicated
a financial or other interest that is relevant to the subject matter under consideration in this …

[HTML][HTML] Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists

…, J Seekins, TJ Amrhein, DA Mong, SS Halabi… - PLoS …, 2018 - journals.plos.org
Background Chest radiograph interpretation is critical for the detection of thoracic diseases,
including tuberculosis and lung cancer, which affect millions of people worldwide each year. …

[PDF][PDF] Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study

PW Kantoff, S Halabi, M Conaway, J Picus… - Journal of Clinical …, 1999 - researchgate.net
Purpose: Approximately 40,000 men die each year of hormone-refractory prostate cancer (HRPC).
The results of treatment with chemotherapy have been disappointing to date, with no …